Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 19, 2009
Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOPHeidi Nyman, Mats Jerkeman, Marja-Liisa Karjalainen-Lindsberg, et al.
British Journal of Haematology|May 10, 2017
The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group studyHenrik Cederleuf, Martin Bjerregård Pedersen, Mats Jerkeman, et al.
Pharmaceutical Medicine|January 15, 2020
Monitoring CAR-T-Cell Therapies Using the Nordic Healthcare DatabasesTorbjörn Callréus, Tarec Christoffer El-Galaly, Mats Jerkeman, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|December 26, 2023
Evidence for distinct mechanisms of immune suppression in EBV-positive and EBV-negative Hodgkin lymphomaMakka Adam, Yonas Bekuretsion, Amha Gebremedhin, et al.
BMC Cancer|December 8, 2020
Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on riskLavanya Lokhande, Venera Kuci Emruli, Arne Kolstad, et al.
European Journal of Haematology|July 20, 2007
Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphomaJohan Linderoth, Mats Ehinger, Måns Akerman, et al.
International Journal of Cancer|November 5, 2025
Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphomaSara Ekberg, Ingrid Glimelius, Alexandra Albertsson-Lindblad, et al.
Pageof 17